Business

Business Casey Ross and Mohana Ravindranath

STAT Plus: Why Google and Microsoft can’t defuse U.S. health care’s ticking cybersecurity problem

Health tech Brittany Trang

STAT Plus: Google’s Verily to offer GLP-1 drugs through Lightpath, its retooled chronic care app

The Readout Elaine Chen

Eli Lilly’s Alzheimer’s candidate, Bob Langer’s new startup, and other biotech news you need to know

The Readout Meghana Keshavan

The biotech news you missed from the weekend

Health tech Mohana Ravindranath

STAT Plus: Teladoc has a new CEO, but challenges remain the same

The Readout Meghana Keshavan

STAT Plus: Vanda Pharmaceuticals has another suitor

Business Bob Herman

STAT Plus: Cigna wins case to block former executive from jumping to CVS

The Readout Elaine Chen

Novavax will be able to supply Covid-19 vaccines this fall

The Readout Jason Mast

STAT Plus: Testing begins for a new form of PrEP

Business Bob Herman

STAT Plus: Medicare Advantage plan’s quality ratings were incorrectly calculated by government, judge rules

The Readout Elaine Chen

STAT Plus: Operation Warp Speed but for rare disease

Special Report Lizzy Lawrence

STAT Plus: How a device maker inundated pain patients with unwanted batteries and surprise bills

Health tech Lizzy Lawrence

STAT Plus: 5 takeaways from STAT’s look at unwanted supplies and surprise bills from device maker Zynex Medical

Health tech Lizzy Lawrence

STAT Plus: Becton Dickinson to buy Edwards patient monitoring unit for $4.2 billion

The Readout Meghana Keshavan

STAT Plus: Can AstraZeneca make good on its promise?

Business Brittany Trang

STAT Plus: Elevance PBM’s president out as customers complain of prescription chaos

Business Brittany Trang

STAT Plus: HHS: Change Healthcare can make data breach notifications in lieu of hospitals

The Readout Meghana Keshavan

STAT Plus: The surprising outperformance of a new drug against existing competitors, and other biotech updates

The Readout Elaine Chen

STAT Plus: Biohaven’s autoimmune drug disappoints, and other biotech news updates from the week

Health tech Mario Aguilar

STAT Plus: Akili, maker of a video game to treat ADHD, to be acquired for $34 million

The Readout Elaine Chen

STAT Plus: Wegovy linked to lower risk of alcohol use disorder in real-world study

The Readout Meghana Keshavan

STAT Plus: Biotech’s most interesting fundraisings from the last week

The Readout Meghana Keshavan

STAT Plus: More tumult at BIO amid the company’s fourth CEO in four years

The Readout Elaine Chen

STAT Plus: In light of H5N1 outbreak, U.S. in talks with mRNA vaccine makers on bird flu

Health tech Brittany Trang

STAT Plus: Cue Health, Covid-19 testing company, is shutting down

Health tech Mario Aguilar

STAT Plus: Eyeing GLP-1 opportunity, Click buys assets of Better Therapeutics

The Readout Elaine Chen

STAT Plus: Maryland takes first steps to cap drug costs

The Readout Elaine Chen

STAT Plus: Lilly doubles down on radiopharma

The Readout Meghana Keshavan

STAT Plus: The biotech news you need to read this morning